{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:26:30Z","timestamp":1790317590116,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2017R1A2B2005612"],"award-info":[{"award-number":["NRF-2017R1A2B2005612"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.06.148","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T13:22:38Z","timestamp":1530192158000},"page":"2271-2276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Induction of pigmentation by a small molecule tyrosine kinase inhibitor nilotinib"],"prefix":"10.1016","volume":"503","author":[{"given":"Kyung-Il","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeung-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-6491","authenticated-orcid":false,"given":"Chang Deok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.06.148_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5021\/ad.2016.28.3.279","article-title":"Skin pigmentation and pigmentary disorders: focus on epidermal\/dermal cross-talk","volume":"28","author":"Bastonini","year":"2016","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.bbrc.2018.06.148_bib2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1523-1747.1998.00178.x","article-title":"Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis","volume":"110","author":"Kobayashi","year":"1998","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2018.06.148_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/pcmr.12365","article-title":"Skin phototype: a new perspective","volume":"28","author":"Maresca","year":"2015","journal-title":"Pigm. Cell. Malenoma. Res."},{"key":"10.1016\/j.bbrc.2018.06.148_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1039\/b201230h","article-title":"UV-induced DNA damage and repair: a review","volume":"1","author":"Sinha","year":"2002","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.bbrc.2018.06.148_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cell.2006.12.045","article-title":"Central role of p53 in the suntan response and pathologic hyperpigmentation","volume":"128","author":"Cui","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.06.148_bib6","first-page":"47","article-title":"Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation","volume":"58","author":"Im","year":"1998","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.06.148_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: from UV carcinogenesis to a new era in therapeutics","volume":"346","author":"Lo","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.06.148_bib8","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.3390\/ijms15058293","article-title":"Inhibitors of intracellular signaling pathways that lead to stimulated epidermal pigmentation: perspective of anti-pigmenting agents","volume":"15","author":"Imokawa","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2018.06.148_bib9","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbrc.2018.06.148_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2016.1256882","article-title":"Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors","volume":"32","author":"Pillaiyar","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2018.06.148_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2005.01.020","article-title":"AMN107: tightening the grip of imatinib","volume":"7","author":"O'Hare","year":"2005","journal-title":"Canc. Cell"},{"issue":"4","key":"10.1016\/j.bbrc.2018.06.148_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/pcmr.12235","article-title":"The biology of hyperpigmentation syndromes","volume":"27","author":"Speeckaert","year":"2014","journal-title":"Pigm. Cell. Malenoma. Res."},{"key":"10.1016\/j.bbrc.2018.06.148_bib13","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/jid.2014.161","article-title":"UV signaling pathways within the skin","volume":"134","author":"Chen","year":"2014","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2018.06.148_bib14","doi-asserted-by":"crossref","first-page":"33690","DOI":"10.1074\/jbc.M202939200","article-title":"Glycogen synthase kinase 3\u03b2 is activated by cAMP and plays an active role in the regulation of melanogenesis","volume":"277","author":"Khaled","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.06.148_bib15","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1172\/JCI59763","article-title":"Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism","volume":"121","author":"Manga","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.06.148_bib16","first-page":"1413","article-title":"Repurposing of drugs for dermatologic applications: five key medications","volume":"13","author":"Adler","year":"2014","journal-title":"J.\u00a0Drugs Dermatol. JDD"},{"key":"10.1016\/j.bbrc.2018.06.148_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-018-0158-9","article-title":"Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib","author":"van der Wagen","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbrc.2018.06.148_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1470-2045(18)30143-8","article-title":"Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial","volume":"19","author":"Gelderblom","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2018.06.148_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13395-018-0150-5","article-title":"Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation","volume":"8","author":"Contreras","year":"2018","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.bbrc.2018.06.148_bib20","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201707918","article-title":"Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer","volume":"10","author":"Jeitany","year":"2018","journal-title":"EMBO Mol. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18314670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18314670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:27:40Z","timestamp":1757762860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18314670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18314670"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.148","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of pigmentation by a small molecule tyrosine kinase inhibitor nilotinib","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}